Cancerous disease modifying antibodies
Cancerous disease modifying antibodies
CD 19×CD3 specific polypeptides and uses thereof
CD2-binding domain of lymphocyte function associated antigen-3
Cell surface protein and effector cell bonding reagent
Cellular and serum protein anchors and conjugates
Cellular and serum protein anchors for modulating pharmacokineti
Chimeric and humanized antibodies to α5β1...
Chimeric and humanized antibodies to α5β1...
Chimeric and radiolabelled antibodies specific to human CD20...
Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D...
Chimeric antibody with specificity to human B cell surface antig
Chimeric antibody with specificity to human B cell surface...
Chimeric immunoglobulin for CD4 receptors
Chimeric protein for prevention and treatment of HIV infection
Chimeric proteins with cell-targeting specificity and...
Chimeric, human and humanized anti-CSAP monoclonal antibodies
Chimeric, human and humanized anti-granulocyte antibodies...
Chronic lymphocytic leukemia cell line
Colony stimulating factor 1 receptor (CSF1R) extracellular...